+ Watch ATRS
on My Watchlist
The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.
I really feel like this is a company worth while to everyone in times of uncertainty. Though there is some volatility associated with the company related to the overall health of the market, with a balance sheet that has NO debt, and several items in development and out already, not to mention a recent partnership with Pfiser, this company really seems like it is an absolute STEAL right now below $5 a share. Will only go up.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions